Overview of FDA Draft Guidance
The FDA is attempting to repeal historic guidance documents (CPG 400.400) Conditions Under Which Homeopathic Drugs May Be Marketed, that has for decades acknowledged and protected the unique nature of homeopathic remedies and provided clear guidance to manufacturers regarding the marketing of these remedies. Over the past few months our industry representatives and consumer activists have worked together…